معرفی
Álvaro Alonso is a Professor of Epidemiology at the Rollins School of Public Health, Emory University. He holds the Stephen D. Clements Jr. Chair in Cardiovascular Disease Prevention. His research focuses on cardiovascular and neurological epidemiology, particularly the prevention of diseases such as atrial fibrillation, cognitive decline, and dementia. Dr. Alonso earned his M.D. and Ph.D. in epidemiology from the University of Navarra, Spain, followed by postdoctoral training at the Harvard School of Public Health under a Fulbright fellowship.
Key affiliations include the PREDIMED-Plus Study (testing lifestyle interventions for cardiovascular prevention), the Goizueta Alzheimer's Disease Research Center (focusing on cognitive aging), and the Atherosclerosis Risk in Communities (ARIC) Study (investigating cardiovascular outcomes). His work spans clinical trials, observational studies, and translational research, addressing topics like anticoagulant effectiveness, biomarker development, and environmental health impacts (e.g., wildfire smoke exposure).
Research interests emphasize the interplay between cardiovascular health and neurodegeneration, leveraging large cohort studies to identify risk factors and preventive strategies. He collaborates internationally, contributing to genomic and proteomic studies of atrial fibrillation and Alzheimer’s disease. His studies often integrate imaging (e.g., echocardiography, neuroimaging) with biomarker and epidemiological data to advance disease understanding.
Publications highlight contributions to atrial fibrillation pathophysiology, lifestyle interventions, and cardiovascular-neurological comorbidities. He leads interdisciplinary teams exploring the societal and clinical implications of chronic diseases, including disparities in healthcare access and outcomes.
